Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

150 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings

NCT04931251

Conditions
Behavior, Behavioral Symptoms, Carcinoma, +5 more
Locations
  • NC Basnight Cancer Hospital Chapel Hill, North Carolina, United States
  • Novant Health Charlotte, North Carolina, United States
  • Vidant Medical Center, Cancer Center Greenville, North Carolina, United States
  • Pardee UNC Health Care, Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details
Completed

A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

NCT00532155

Conditions
Carcinoma, Lung Diseases, Lung Neoplasms, +8 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • sanofi-aventis Australia & New Zealand administrative office Macquarie Park, New South Wales, Australia
  • Sanofi-Aventis Administrative Office Vienna, Austria
View all 32 locations
View Trial Details
Completed

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

NCT05188729

Conditions
Basal Cell Carcinoma, Cancer of the Skin, Cancer of the Skin, Basal Cell, +11 more
Locations
  • Therapeutics Clinical Research San Diego, California, United States
  • ClearlyDerm Boca Raton, Florida, United States
  • Life Clinical Trials Coral Springs, Florida, United States
  • Florida Center for Dermatology Saint Augustine, Florida, United States
View all 13 locations
View Trial Details
Completed

Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

NCT04362072

Conditions
Carcinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations
  • UCI Medical Center/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Rajiv Gandhi Cancer Institute And Research Centre New Delhi, DEL, India
  • Healthcare Global Enterprises Bengaluru, Karnataka, India
  • Bhakti Vedanta Hospital and Research Institute Thane, Maharashtra, India
View all 31 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Existential Distress in Patients with Advanced Cancer and Their Caregivers

NCT04600206

Conditions
Carcinoma, Mental Disorders, Necrophobia, +5 more
Locations
  • LungenClinic Grosshansdorf Hamburg, Free and Hanseatic City of Hamburg, Germany
  • Center for Oncology, University Medical Center Hamburg-Eppendorf Hamburg, Germany
  • Albertinen Krankenhaus Hamburg, Germany
  • Gynecological Outpatient Clinic, University Medical Center Hamburg-Eppendorf Hamburg, Germany
View Trial Details

Related conditions